JOURNAL BROWSE
Search
Advanced SearchSearch Tips
Double-culture Method Enhances the in Vitro Inhibition of Atopy-inducing Factors by Lactococcus lactis
facebook(new window)  Pirnt(new window) E-mail(new window) Excel Download
  • Journal title : Journal of Life Science
  • Volume 25, Issue 7,  2015, pp.810-818
  • Publisher : Korean Society of Life Science
  • DOI : 10.5352/JLS.2015.25.7.810
 Title & Authors
Double-culture Method Enhances the in Vitro Inhibition of Atopy-inducing Factors by Lactococcus lactis
Jo, Yu Ran; Kang, Sang Mo; Kim, Hyun Pyo;
  PDF(new window)
 Abstract
We analyzed whether lactic acid bacteria could control the expression of IL-4 and IL-13 in activated mast cells and whether these bacteria could inhibit the activity of transcription factors such as GATA-1, GATA-2, NF-AT1, NF-AT2, and NF-κB p65. We previously described a technique for identification of lactic acid bacteria with anti-atopy functionality by confirming increased expression of CD4+/CD25+/foxp3+ in T cells. We also confirmed that a double-culture method increased the antibacterial activity of these lactic acid bacteria against Staphylococcus aureus (S. aureus). In the present study, we characterized the effect of lactic acid bacteria cultured by this double-culture method on inhibition of allergic inflammatory reactions of RBL-2H3 mast cells, a cellular model of atopic dermatitis. The strongest anti-allergic effects of the lactic acid bacteria were seen in the following order: Lactococcus lactis broth cultured with medium containing Lactobacillus plantarum culture supernatant > Lc. lactis > Lc. lactis broth cultured with medium containing Lb. plantarum culture supernatant > Lb. plantarum. Thus, Lc. lactis cultured in medium containing Lb. plantarum culture supernatant had the strongest inhibitory effect on the differentiation of mast cells during allergic reactions, which may be mediated through the selective regulation of expression of relevant genes.
 Keywords
Anti-allergy;anti-atopy;lactic acid bacteria;Lactobacillus plantarum;Lactococcus lactis;
 Language
English
 Cited by
 References
1.
Albanesi, C., Fairchild, H. R., Madonna, S., Scarponi, C., De Pitá, O., Leung, D. Y. and Howell, M. D. 2007. IL-4 and IL-13 negatively regulate TNF-alpha- and IFN-gamma-induced beta-defensin expression through STAT-6, suppressor of cytokine signaling (SOCS)-1, and SOCS-3. J. Immunol. 179, 984-992. crossref(new window)

2.
Alkalay, I., Yaron, A., Hatzubai, A., Orian, A., Ciechanover, A. and Ben-Neriah, Y. 1995. Stimulation-dependent I kappa B alpha phosphorylation marks the NF-κB inhibitor for degradation via the ubiquitin-proteasome pathway. Proc. Natl. Acad. Sci. USA 92, 10599-10603. crossref(new window)

3.
Baeuerle, P. A. and Baltimore, D. 1988. IκB: a specific inhibitor of the NF-κB transcription factor. Science 242, 540-546. crossref(new window)

4.
Baeuerle, P. A. and Baltimore, D. 1996. NF-κB: ten years after. Cell 87, 13-20. crossref(new window)

5.
Beaulieu, J., Girad, D., Dupont, C. and Lemieux, P. 2009. Inhibition of neutrophil infiltration by a malleable protein matrix of lactic acid bacteria-fermented whey proteins in vivo. Inflamm. Res. 58, 133-138 crossref(new window)

6.
Brockman, J. A., Scherer, D. C., McKinsey, T. A., Hall, S. M., Qi X., Lee, W. Y. and Ballard, D. W. 1995. Coupling of a signal response domain in I kappa B alpha to multiple pathways for NF-kappa B activation. Mol. Cell. Biol. 15, 2809-2818. crossref(new window)

7.
Burgos-Ramos, E., Canelles, S., Perianes, C. A., Arilla, F. E., Argente, J. and Barrios, V. 2012. Adipose tissue promotes a serum cytokine profile related to lower insulin sensitivity after chronic central leptin infusion. PLoS One 7, e46893. crossref(new window)

8.
Chen, Z. J., Parent, L. and Maniatis, T. 1996. Site-specific phosphorylation of IκBα by a novel ubiquitination-dependent protein kinase activity. Cell 84, 853-862. crossref(new window)

9.
Crabtree, G. R. 1999. Generic signals and specific outcomes: signaling through Ca2+, calcineurin, and NF-AT. Cell 96, 611-614. crossref(new window)

10.
Finco, T. S. and Baldwin, A. S. 1995. Mechanistic aspects of NF-κB regulation: the emerging role of phosphorylation and proteolysis. Immunity 3, 263-272. crossref(new window)

11.
Granlund, H., Erkko, P., Sinisalo, M. and Reitamo, S. 1995. Cyclosporin in atopic dermatitis: time to relapse and effect of intermittent therapy. Br. J. Dermatol. 132, 106-112. crossref(new window)

12.
Harigae, H., Takahashi, S., Suwabe, N., Ohtsu, H., Gu, L., Yang, Z., Tsai, F. Y., Kitamura, Y., Engel, J. D. and Yamamoto, M. 1998. Differential roles of GATA-1 and GATA-2 in growth and differentiation of mast cells. Genes Cells 3, 39-50. crossref(new window)

13.
Hatano, Y., Terashi, H., Arakawa, S. and Katagiri, K. 2005. Interleukin-4 suppresses the enhancement of ceramide synthesis and cutaneous permeability barrier functions induced by tumor necrosis factor-alpha and interferon-gamma in human epidermis. J. Invest. Dermatol. 124, 786-792. crossref(new window)

14.
Hayashi, A., Kimura, M., Nakamura, Y. and Yasui, H. 2009. Anti-atopic dermatitis effects and the mechanism of lactic acid bacteria isolated from Mongolian fermented milk. J. Dairy Res. 76, 158-164. crossref(new window)

15.
Heyman, M., Terpend, K. and Menard, S. 2005. Effects of specific lactic acid bacteria on the intestinal permeability to macromolecules and the inflammatory condition. Acta Paediatr. Suppl. 94, 34-36 crossref(new window)

16.
Hirasawa, N., Sato, Y., Fujita, Y. and Ohuchi, K. 2000. Involvement of a phosphatidylinositol 3-kinase-p38 mitogen activated protein kinase pathway in antigen-induced IL-4 production in mast cells. Biochem. Biophys. Acta. 1456, 45-55.

17.
Hirasawa, R., Shimizu, R., Takahashi, S., Osawa, M., Takayanagi, S., Kato, Y., Onodera, M., Minegishi, N., Yamamoto, M., Fukao, K., Taniguchi, H., Nakauchi, H. and Iwama, A. 2002. Essential and instructive roles of GATA factors in eosinophil development. J. Exp. Med. 195, 1379-1386. crossref(new window)

18.
Jo, Y. R. and Kang, S. M. 2012. Lactococcus lactis culture method for enhanced depression of inducer in atopic diseases. Kor. J. Microbiol. Biotechnol. 40, 310-318. crossref(new window)

19.
Kalliomäki, M., Salminen, S., Arvilommi, H., Kero, P., Koskinen, P. and Isolauri, E. 2001. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 357, 1076-1079. crossref(new window)

20.
Khani, S., Hosseini, H. M., Taheri, M., Nourani, M. R. and Imani Fooladi, A. A. 2012. Probiotics as an alternative strategy for prevention and treatment of human diseases: areview. Inflamm. Allergy Drug Targets 11, 79-89. crossref(new window)

21.
Kim, B. E., Leung, D. Y., Boguniewicz, M. and Howell, M. D. 2008. Loricrin and involucrin expression is down-regulated by Th2 cytokines through STAT-6. Clin. Immunol. 126, 332-337. crossref(new window)

22.
Klein, M., Klein, H. S., Palmetshofer, A., Serfling, E., Tertilt, C., Bopp, T., Heib, V., Becker, M., Taube, C., Schild, H., Schmitt, E. and Stassen, M. 2006. Specific and redundant roles for NFAT transcription factors in the expression of mast cell-derived cytokines. J. Immunol. 177, 6667-6674. crossref(new window)

23.
Kurahashi, R., Hatano, Y. and Katagiri, K. 2008. IL-4 suppresses the recovery of cutaneous permeability barrier functions in vivo. J. Invest. Dermatol. 128, 1329-1331. crossref(new window)

24.
Lee, H. Y., Kim, M. K., Park, K. S., Shin, E. H., Jo, S. H., Kim, S. D., Jo, E. J., Lee, Y. N., Lee, C., Baek, S. H. and Bae, Y. S. 2006. Serum amyloid A induces contrary immune responses via formyl peptide receptor-like 1 in human monocytes. Mol. Pharmacol. 70, 241-248.

25.
Lee, J., Seto D. and Bielory, L. 2008. Meta-analysis of clinical trials of probiotics for prevention and treatment of pediatric atopic dermatitis. J. Allergy Clin. Immunol. 121, 116-121 crossref(new window)

26.
Leung, D. Y. 1999. Pathogenesis of atopic dermatitis. J. Allergy Clin. Immunol. 104, 99-108. crossref(new window)

27.
Leung, D. Y. and Soter, N. A. 2001. Cellular and immunologic mechanisms in atopic dermatitis. J. Am. Acad. Dermatol. 44, S1-S12. crossref(new window)

28.
Lewin, I., Nechushtan, H., Ke, Q. and Razin, E. 1993. Regulation of AP-1 expression and activity in antigen-stimulated mast cells: the role played by protein kinase C and the possible involvement of Fos interacting protein. Blood 82, 3745-3751.

29.
Liong, M. T. 2008. Roles of probiotics and prebiotics in colon cancer prevention: postulated mechanisms and in-vivo evidence. Int. J. Mol. Sci. 9, 854-863. crossref(new window)

30.
Masuda, A., Yoshikai, Y., Kume, H. and Matsuguchi, T. 2004. The interaction between GATA proteins and activator protein-1 promotes the transcription of IL-13 in mast cells. J. Immunol. 173, 5564-5573. crossref(new window)

31.
Matsubara, M., Masaki, S., Ohmori, K., Karasawa, A. and Hasegawa, K. 2004. Differential regulation of IL-4 expression and degranulation by anti-allergic olopatadine in rat basophilic leukemia (RBL_2H3) cells. Biochem. Pharmacol. 67, 1315-1326. crossref(new window)

32.
McNagny, K. and Graf, T. 2002. Making eosinophils through subtle shifts in transcription factor expression. J. Exp. Med. 195, 43-47. crossref(new window)

33.
Min, Y. D., Choi, C. H., Bark, H., Son, H. Y., Park, H. H., Lee, S., Park, J. W., Park, E. K., Shin, H. I. and Kim, S. H. 2007. Quercetin inhibits expression of inflammatory cytokines through attenuation of NF-kappaB and p38 MAPK in HMC-1 human mast cell line. Inflamm. Res. 56, 210-215. crossref(new window)

34.
Moroi, M., Uchi, S., Nakamura, K., Sata, S., Shimizu, N., Fujji, M., Kumagai, T., Saito, M., Uchiyama, K., Watanabe, T., Yamaguchi, H., Yamamoto, T., Takeuchi, S. and Furue, M. 2011. Beneficial effect of a diet containing heat-killed Lactobacillus paracasei K71 on adult type atopic dermatitis. J. Dermatol. 38, 131-139 crossref(new window)

35.
Nerlov, C. and Graf, T. 1998. PU.1 induces myeloid lineage commitment in multipotent hematopoietic progenitors. Genes Dev. 12, 2403-2412. crossref(new window)

36.
Ooi, L. G. and Liong, M. T. 2010. Cholesterol-lowering effects of probiotics and prebiotkcs: A revkew of in vivo and in vitro findings. Int. J. Mol. Sci. 11, 2499-2522 crossref(new window)

37.
Reber, L., Vermeulen, L., Haegeman, G. and Frossard, N. 2009. Ser276 Phosphorylation of NF-kB p65 by MSK1 Controls SCF Expression in Inflammation. PLoS ONE 4, e4393. crossref(new window)

38.
Salek, M. S., Finlay, A. Y., Luscombe, D. K., Allen, B. R., Berth-Jones, J., Camp, R. D., Graham-Brown, R. A., Khan, G. K., Marks, R. and Motley, R. J. 1993. Cyclosporin greatly improves the quality of life of adults with severe atopic dermatitis. A randomized, double-blind, placebo-controlled trial. Br. J. Dermatol. 129, 422-430. crossref(new window)

39.
Shah, M. M., Miyamoto, Y., Yamada, Y., Yamashita, H., Tanaka, H., Ezaki, T., Nagai, H. and Inagaki, N. 2010. Orally supplemented lactobacillus acidophilus strain L-92 inhibits passive and active cutaneous anaphylaxis as well as 2,4-dinitroflurobenzene and mite fecal antigen induced atopic dermatitis-like skin lesions in mice. Microbiol. Immunol. 54, 523-533. crossref(new window)

40.
Sistek, D., Kelly, R., Wickens, K., Stanley, T., Fitzharris, P. and Crane, J. 2006. Is the effect of probiotics on atopic dermatitis confined to food sensitized children? Clin. Exp. Allergy 36, 629-633. crossref(new window)

41.
Sohn, E. H., Jang, S. A., Joo, H., Park, S., Kang, S. C., Lee, C. H. and Kim, S. Y. 2011 Anti-allergic and anti-inflammatory effects of butanol extract from Arctium Lappa L. Clin. Mol. Allergy 9, 4. crossref(new window)

42.
Thanos, D. and Maniatis, T. 1995. NF-kappa B: a lesson in family values. Cell 80, 529-532. crossref(new window)

43.
Watanabe, T., Hamada, K., Tategaki, A., Kishida, H., Kitano, M. and Miyamoto, T. 2009. Oral administration of lactic acid bacteria isolated from traditional south Asian fermented milk ‘dahi’ inhibits the development of atopic dermatitis in NC/Nga mice. J. Nutr. Sci. Vitaminol. (Tokyo) 55, 271-278 crossref(new window)

44.
Weiss, D. L., Hural, J., Tara, D., Timmerman, L. A., Henkel, G. and Brown, M. A. 1996. Nuclear factor of activated T cells is associated with a mast cell interleukin 4 transcription complex. Mol. Cell Biol. 16, 228-235. crossref(new window)

45.
Winter, G. and Harris, W. J. 1993. Humanized antibodies. Immunol. Today 14, 243-246. crossref(new window)

46.
Wu, Z., Turner, D. R. and Oliveira, D. B. 2001. IL-4 gene expression up-regulated by mercury in rat mast cells: a role of oxidant stress in IL-4 transcription. Int. Immunol. 13, 297-304. crossref(new window)